Functional magnetic particles for medical application

Journal of Bioscience and Bioengineering

Volumn 94, Issue 6, 2002, Pages 606-613

  Shinkai, Masashige ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Drug delivery; Hyperthermia; Magnetic carrier; Magnetic particle; Magnetic resonance imaging

Indexed keywords

CELLS; DNA; DRUG DOSAGE; MAGNETIC MATERIALS; MAGNETIC RESONANCE IMAGING; SEPARATION; TUMORS;

IMMUNOASSAYS;

BIOTECHNOLOGY;

CANCER ANTIBODY; DEXTRAN MAGNETITE; DNA; GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN F(AB) FRAGMENT; IRON OXIDE; MAGNETITE; MAGNETITE CATIONIC LIPOSOME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CANCER; CANCER THERAPY; CONTRAST ENHANCEMENT; DNA TRANSFER; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; HYPERTHERMIA; IMMUNOASSAY; KIDNEY CARCINOMA; MAGNET; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SEPARATION TECHNIQUE; TUMOR IMMUNITY;

EID: 0036971119     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-1723(02)80202-X     Document Type: Review

References (57)

1. Dunnill, P. and Lilly, M. D.: Purification of enzymes using magnetic bioaffinity materials. Biotechnol. Bioeng., 16, 987-990 (1974).
2. Mosbach, K. and Anderson, L.: Magnetic ferrofluids for prepareation of magnetic polymers and their application in affinity chromatography. Nature, 270, 259-261 (1977).
3. Kondo, A., Kamura, H., and Higashitani, K.: Development and application of thermosensitive magnetic immunomicrospheres for antibody purification. Appl. Microbiol. Biotech., 41, 99-105 (1994).
4. Kondo, A. and Fukuda, H.: Preparation of thermo-sensitive magnetic hydrogel microspheres and application to enzyme immobilization. J. Ferment. Bioeng., 84, 337-341 (1997).
5. Stechell, C. H.: Magnetic separations in biotechnology - a review. J. Chem. Technol. Biotechnol., 35B, 175-182 (1985).
6. Barclay, A. N., Brown, M. L., Beyers, A. D., Davis, S. J., and Somoza, C., Williams, A. F.: The leukocytes antigen facts book. Academic Press, San Diego, CA (1993).
7. Weber, C. and Falkenhagen, D.: Specific blood purification by means of antibody-conjugated magnetic microspheres, p. 371-378. In Häfeli, U., Shutt, W., Teller, J., and Zborowski, M. (ed.), Scientific and clinical application of magnetic carriers. Plenum Press, New York (1997).
8. Guesdon, J. L., Thiery, R., and Avrameas, S.: Magnetic enzyme immunoassay for measuring human IgE. J. Allergy Clin. Immunol., 6, 23-27 (1978).
9. Druet, E., Mahieu, P., Foidart, J. M., and Druet, P.: Magnetic solid-phase enzyme immunoassay for the detection of anti-glomerular basement membrane antibodies. J. Immnol. Methods, 48, 149-157 (1982).
10. Pazzagli, M., Kohen, F., Sufi, S., Masironi, B., and Cekan, S. Z.: Immunometric assay for lutropin (hLH) based on the use of universal reagents for enzymatic labeling and magnetic separation and monitored by enhanced chemiluminescence. J. Immunol. Methods, 114, 62-68 (1988).
11. Vonk, G. P. and Schram, J. L.: Dual-enzyme cascade-magnetic separation immunoassay for respiratory syncytial virus. J. Immunol. Methods, 137, 133-139 (1991).
12. Shinkai, M., Wang, J., Kamihira, M., Iwata, M., Honda, H., and Kobayashi, T.: Rapid enzyme-linked immunosorbent assay with functional magnetite particles. J. Ferment. Bioeng., 73, 166-168 (1992).
13. Bergemann, C., Müller-Schulte, D., Oster, J., à Brassard, L., and Lübbe, A. S.: Magnetic ion-exchange nano- and microparticles for medical, biochemical and molecular biological applications. J. Magn. Magn. Mater., 194, 45-52 (1999).
14. Nagatani, N., Shinkai, M., Honda, H., and Kobayashi, T.: Development of a new transformation method using magnetite cationic liposomes and magnetic selection of transformed cells. Biotechnol. Lett., 22, 999-1002 (2000).
15. Shinkai, M., Yanase, M., Honda, H., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Intracellular hyperthermia for cancer using magnetite cationic liposome: in vitro study. Jpn. J. Cancer Res., 87, 1179-1183 (1996).
16. Schneider, S. and Rusconi, S.: Magnetic selection of transiently transfected cells. Biotechniques, 21, 876-880 (1996).
17. Padmanabhan, R., Corsico, C. D., Howard, T. H., Holter, W., Fordis, C. M., Willingham, M., and Howard, B. H.: Purification of transiently transfected cells by magnetic affinity cell sorting. Anal. Biochem., 170, 341-348 (1988).
18. Widder, K. J., Senyei, A. E., and Scarpelli, D. G.: Magnetic microspheres: a model system for site specific drug delivery in vivo. Proc. Soc. Exp. Biol. Med., 58, 141-146 (1978).
19. Morimoto, Y., Okumura, M., Sugibayashi, K., and Kato, Y.: Preparation and magnetic guidance of magnetic albumin microspheres for site specific drug delivery in vivo. J. Pharm. Dyn., 4, 624-631 (1981).
20. Widder, K. J., Morris, R. M., Poore, G., Howard, D. P., Jr., and Senyei, A. E.: Tumor remission in Yoshida sarcoma-bearing rats by selective targeting of magnetic albumin microspheres containing doxorubicin. Proc. Natl. Acad. Sci. USA, 78, 579-581 (1981).
21. Suzuki, M., Shinkai, M., Yanase, M., Ito, A., Honda, H., and Kobayashi, T.: Enhancement of uptake of magnetoliposomes by magnetic force and hyperthermic effect on tumor. Jpn. J. Hyperthermic Oncol., 15, 79-87 (1999).
22. Magin, R. L., Wright, S. M., Niesman, M. R., Chan, H. C., and Swartz, H. M.: Liposome delivery of NMR contrast agents for improved tissue imaging. Magn. Reson. Med., 3, 440-447 (1986).
23. Gillis, P. and Koenig, S. H.: Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite. Magn. Reson. Med., 5, 323-345 (1987).
24. Saini, S., Stark, D. D., Hahn, P. F., Wittenberg, J., Brady, T. J., and Ferrucci, J. T.: Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology, 162, 211-216 (1987).
25. Stark, D. D., Weissleder, R., Elizondo, G., Hahn, P. F., Saini, S., Todd, L. E., Wittenberg, J., and Ferrucci, J. T.: Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology, 168, 297-301 (1988).
26. Josephson, L., Groman, E. V., Menz, E., Lewis, J. M., and Bengele, H.: A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. Magn. Reson. Imaging, 8, 637-646 (1990).
27. Suzuki, M., Honda, H., Kobayashi, T., Wakabayashi, T., Yoshida, J., and Takahashi, M.: Development of a target-directed magnetic resonance contrast agent using monoclonal antibody-conjugated magnetic particles. Brain Tumor Pathol., 13, 127-132 (1996).
28. Bushida, K., Mohri, K., Katoh, T., and Kobayashi, A.: Amorphous wire MI micro magnetic sensor for gradient field detection. IEEE Trans. Mag., 32, 4944-4946 (1996).
29. Shinkai, M., Ohshima, A., Yanase, M., Uchiyama, T., Mohri, K., Wakabayashi, T., Yoshida, J., Honda, H., and Kobayashi, T.: Development of novel magnetic sensing for brain lesion using functional magnetic particles. Kagaku Kogaku Ronbunnshu, 24, 174-178 (1998). (in Japanese)
30. Cavaliere, R., Ciocatto, E. C., Giovanella, B. C., Heidelburger, C., Jonson, R. O., Margottini, M., Mondovi, B., Moricca, B. G., and Rossi-Fanelli, A.: Selective heat sensitivity of cancer cells. Cancer, 20, 1351-1381 (1967).
31. Ikeda, N., Hayashida, O., Kameda, H., Ito, H., and Matsuda, T.: Experimental study on thermal damage to dog normal brain. Int. J. Hyperthermia, 10, 553-561 (1994).
32. Lin, J. C. and Wang, Y. J.: Interstitial microwave antennas or thermal therapy. Int. J. Hyperthermia, 3, 37-47 (1987).
33. Stauffer, P. R., Cetas, T. C., Fletcher, A. M., DeYoung, D. W., Dewhirst, M. W., Oleson, J. R., and Roemer, R. B.: Observation on the use of ferromagnetic implants for inducing hyperthermia. IEEE Trans. Biomed. Eng., BME-31, 76-90 (1984).
34. Takemori, S., Tazawa, K., Nagae, H., Yamashita, I., Kato, H., Kasagi, T., Maeda, M., Honda, T., and Fujimaki, M.: A study of DDS in hyperthermia: inductive heating with use of dextran magnetite (DM). Drug Deliv. Syst., 6, 465-470 (1991).
35. Jordan, A., Wust, P., Fähling, H., John, W., Hinz, A., and Felix, R.: Inductive heating of ferromagnetic particles and magnetic fluids - physical evaluation of their potential for hyperthermia. Int. J. Hyperthermia, 9, 51-68 (1993).
36. Mitsumori, M., Hiraoka, M., Shibata, T., Okuno, Y., Masunaga, S., Konishi, M., Okajima, K., Nagata, Y., Nishimura, Y., Abe, M., and other 4 authers: Development of intraarterial hyperthermia using a dextran-magnetite complex. Int. J. Hyperthermia, 10, 785-793 (1994).
37. Gilchrist, R. K. and David V. C.: Selective inductive heating of lymph nodes. Annal. Surgery, 146, 596-606 (1957).
38. Weinstock, S. B. and Brain, J. D.: Comparison of particle clearance and macrophage phagosomal motion in liver and lungs of rats. J. Appl. Phys., 65, 1811-1820 (1988).
39. Lonnemark, M., Hemmingsson, A., Bach-Gansmo, T., Hagberg, H., Magnusson, A., Gundersen, H.G., and Nyman, R.: Superparamagnetic particles and oral contrast medium in MR imaging of malignant lymphoma. Acta Radiol., 32, 232-238 (1991).
40. Gordon, R. T., Hines, J. R., and Gordon, D.: Intracellular hyperthemia - a biophysical approach to cancer via intracellular temperature and biophysical alterations. Med. Hypothesis, 5, 83-102 (1979).
41. Jordan, A., Wust, P., Scholz, R., Tesch, B., Fähling, H., Mitrovics, T., Vogl, T., Cervós-Navarro, J., and Felix, R.: Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int. J. Hyperthermia, 12, 705-722 (1996).
42. Chan, D. C. F., Kirpotin, D. B., and Bunn, P. A.: Synthesis and evaluation of colloidal magnetic iron-oxides for the site-specific radiofrequency-induced hyperthermia of cancer. J. Magn. Magn. Mater., 122, 374-378 (1993).
43. Shinkai, M., Matsui, M., and Kobayashi, T.: Heat properties of magnetoliposomes for local hyperthermia. Jpn. J. Hyperthermic Oncol., 10, 168 (1994).
44. Yanase, M., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. Jpn. J. Cancer Res., 88, 630-632 (1997).
45. Yanase, M., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. Jpn. J. Cancer Res., 89, 463-469 (1998).
46. Ohno, T., Wakabayashi, T., Takemura, A., Yoshida, J., Ito, A., Shinkai, M., Honda, H., and Kobayashi, T.: Effective solitary hyperthermia treatment of malignant glioma using stick type CMC-magnetite. In vivo study. J. Neurooncol., 56, 233-239 (2002).
47. Le, B., Shinkai, M., Kitade, T., Honda, H., Yoshida, J., Wakabayashi, T., and Kobayashi, T.: Preparation of tumor-specific magnetoliposomes and their application for hyperthermia. J. Chem. Eng. Jpn., 34, 66-72 (2001).
48. Shinkai, M., Le, B., Honda, H., Yoshikawa, K., Shimizu, K., Saga, S., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes. Jpn. J. Cancer Res., 92, 1138-1145 (2001).
49. Shinkai, M., Suzuki, M., Yokoi, N., Yanase, M., Shimizu, W., Honda, H., and Kobayashi, T.: Development of anticancer drugs-encapsulated magnetoliposome and its combination effect of hyperthermia and chemotherapy. Jpn. J. Hyperthermic Oncol., 14, 15-22 (1998).
50. Yanase, M., Shinkai, M., Suzuki, M., Honda, H., and Kobayashi, T.: Study on thermochemotherapy using magnetic cationic liposomes and anti-cancer drug. Kagaku Kougaku Ronbunshu, 24, 179-183 (1998). (in Japanese)
51. Ito, A., Shinkai, M., Bouhon, I. A., Honda, H., and Kobayashi, T.: Bystander-killing effect and cyclic induction of TNF-α gene under heat-inducible promoter gadd 153. J. Biosci. Bioeng., 90, 437-441 (2000).
52. Ito, A., Shinkai, M., Honda, H., and Kobayashi, T.: Heat-inducible TNF-α gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther., 8, 649-654 (2001).
53. Yanase, M., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn. J. Cancer Res., 89, 775-782 (1998).
54. Ito, A., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immmunol. Immunother., 50, 515-522 (2001).
55. Ménoret, A. and Chandawarkar, R.: Heat-shock protein-based anticancer immunotherapy: an idea whose time has come. Sem. Immunol., 25, 654-660 (1998).
56. Tamura, Y., Peng, P., Liu, K., Daou, M., and Srivastava, P. K.: Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science, 278, 117-120 (1997).
57. Udono, H. and Srivastava, P. K.: Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med., 178, 1391-1396 (1993).